Information Technology Services
Compare Stocks
5 / 10Stock Comparison
EXLS vs ACN vs IBM vs EPAM vs CTSH
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Information Technology Services
Information Technology Services
EXLS vs ACN vs IBM vs EPAM vs CTSH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Information Technology Services | Information Technology Services | Information Technology Services | Information Technology Services | Information Technology Services |
| Market Cap | $4.86B | $112.34B | $215.52B | $5.24B | $24.49B |
| Revenue (TTM) | $2.16B | $72.11B | $68.91B | $5.56B | $21.41B |
| Net Income (TTM) | $252M | $7.68B | $10.75B | $387M | $2.23B |
| Gross Margin | 38.5% | 32.0% | 59.0% | 27.9% | 32.1% |
| Operating Margin | 15.2% | 14.8% | 16.4% | 9.9% | 15.7% |
| Forward P/E | 13.9x | 13.0x | 18.5x | 7.7x | 9.1x |
| Total Debt | $404M | $8.18B | $67.15B | $144M | $1.57B |
| Cash & Equiv. | $146M | $11.48B | $13.64B | $1.30B | $1.90B |
EXLS vs ACN vs IBM vs EPAM vs CTSH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ExlService Holdings… (EXLS) | 100 | 254.1 | +154.1% |
| Accenture plc (ACN) | 100 | 89.5 | -10.5% |
| International Busin… (IBM) | 100 | 192.6 | +92.6% |
| EPAM Systems, Inc. (EPAM) | 100 | 43.0 | -57.0% |
| Cognizant Technolog… (CTSH) | 100 | 97.5 | -2.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EXLS vs ACN vs IBM vs EPAM vs CTSH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EXLS has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 13.6%, EPS growth 27.3%, 3Y rev CAGR 13.9%
- 218.8% 10Y total return vs IBM's 108.0%
- Lower volatility, beta 0.64, Low D/E 44.2%, current ratio 2.56x
- PEG 0.57 vs EPAM's 2.07
ACN is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 14 yrs, beta 0.80, yield 3.2%
- Beta 0.80, yield 3.2%, current ratio 1.42x
- 3.2% yield, 14-year raise streak, vs IBM's 2.9%, (2 stocks pay no dividend)
IBM is the #2 pick in this set and the best alternative if quality and momentum is your priority.
- 15.6% margin vs EPAM's 7.0%
- -6.3% vs EPAM's -44.8%
EPAM ranks third and is worth considering specifically for growth and value.
- 15.4% revenue growth vs CTSH's 7.0%
- Lower P/E (7.7x vs 9.1x)
Among these 5 stocks, CTSH doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.4% revenue growth vs CTSH's 7.0% | |
| Value | Lower P/E (7.7x vs 9.1x) | |
| Quality / Margins | 15.6% margin vs EPAM's 7.0% | |
| Stability / Safety | Beta 0.64 vs EPAM's 1.11 | |
| Dividends | 3.2% yield, 14-year raise streak, vs IBM's 2.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | -6.3% vs EPAM's -44.8% | |
| Efficiency (ROA) | 14.8% ROA vs IBM's 7.1%, ROIC 20.4% vs 9.8% |
EXLS vs ACN vs IBM vs EPAM vs CTSH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EXLS vs ACN vs IBM vs EPAM vs CTSH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IBM leads in 2 of 6 categories
EPAM leads 1 • ACN leads 1 • EXLS leads 0 • CTSH leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
IBM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACN is the larger business by revenue, generating $72.1B annually — 33.4x EXLS's $2.2B. IBM is the more profitable business, keeping 15.6% of every revenue dollar as net income compared to EPAM's 7.0%. On growth, EXLS holds the edge at +13.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.2B | $72.1B | $68.9B | $5.6B | $21.4B |
| EBITDAEarnings before interest/tax | $410M | $12.1B | $15.1B | $696M | $3.9B |
| Net IncomeAfter-tax profit | $252M | $7.7B | $10.8B | $387M | $2.2B |
| Free Cash FlowCash after capex | $297M | $12.5B | $13.1B | $544M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +38.5% | +32.0% | +59.0% | +27.9% | +32.1% |
| Operating MarginEBIT ÷ Revenue | +15.2% | +14.8% | +16.4% | +9.9% | +15.7% |
| Net MarginNet income ÷ Revenue | +11.7% | +10.7% | +15.6% | +7.0% | +10.4% |
| FCF MarginFCF ÷ Revenue | +13.8% | +17.3% | +19.0% | +9.8% | +11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.8% | +8.3% | +9.5% | +7.6% | +5.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +7.5% | +3.9% | +14.3% | +18.8% | +3.7% |
Valuation Metrics
EPAM leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.4x trailing earnings, CTSH trades at a 45% valuation discount to IBM's 20.6x P/E. Adjusting for growth (PEG ratio), EXLS offers better value at 0.83x vs EPAM's 3.98x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.9B | $112.3B | $215.5B | $5.2B | $24.5B |
| Enterprise ValueMkt cap + debt − cash | $5.1B | $109.0B | $269.0B | $4.1B | $24.2B |
| Trailing P/EPrice ÷ TTM EPS | 20.18x | 14.85x | 20.57x | 14.77x | 11.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.91x | 13.00x | 18.47x | 7.69x | 9.07x |
| PEG RatioP/E ÷ EPS growth rate | 0.83x | 1.65x | 1.66x | 3.98x | 0.94x |
| EV / EBITDAEnterprise value multiple | 13.73x | 8.61x | 17.53x | 6.32x | 5.92x |
| Price / SalesMarket cap ÷ Revenue | 2.33x | 1.61x | 3.19x | 0.96x | 1.16x |
| Price / BookPrice ÷ Book value/share | 5.53x | 3.54x | 6.66x | 1.52x | 1.66x |
| Price / FCFMarket cap ÷ FCF | 16.30x | 10.33x | 18.62x | 8.54x | 9.44x |
Profitability & Efficiency
ACN leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
IBM delivers a 35.4% return on equity — every $100 of shareholder capital generates $35 in annual profit, vs $11 for EPAM. EPAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to IBM's 2.05x. On the Piotroski fundamental quality scale (0–9), EXLS scores 7/9 vs IBM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +27.2% | +23.9% | +35.4% | +10.7% | +14.8% |
| ROA (TTM)Return on assets | +14.8% | +11.8% | +7.1% | +8.1% | +10.9% |
| ROICReturn on invested capital | +20.4% | +26.8% | +9.8% | +15.5% | +18.7% |
| ROCEReturn on capital employed | +23.2% | +24.9% | +9.5% | +13.3% | +21.1% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.44x | 0.25x | 2.05x | 0.04x | 0.10x |
| Net DebtTotal debt minus cash | $257M | -$3.3B | $53.5B | -$1.2B | -$326M |
| Cash & Equiv.Liquid assets | $146M | $11.5B | $13.6B | $1.3B | $1.9B |
| Total DebtShort + long-term debt | $404M | $8.2B | $67.2B | $144M | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 11.80x | 40.67x | 6.41x | — | 107.78x |
Total Returns (Dividends Reinvested)
IBM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IBM five years ago would be worth $18,832 today (with dividends reinvested), compared to $2,157 for EPAM. Over the past 12 months, IBM leads with a -6.3% total return vs EPAM's -44.8%. The 3-year compound annual growth rate (CAGR) favors IBM at 26.8% vs EPAM's -24.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -24.6% | -29.3% | -20.0% | -50.5% | -36.0% |
| 1-Year ReturnPast 12 months | -31.7% | -39.5% | -6.3% | -44.8% | -33.2% |
| 3-Year ReturnCumulative with dividends | +3.4% | -25.4% | +103.8% | -57.2% | -10.3% |
| 5-Year ReturnCumulative with dividends | +58.5% | -29.2% | +88.3% | -78.4% | -22.4% |
| 10-Year ReturnCumulative with dividends | +218.8% | +90.1% | +108.0% | +41.5% | -0.4% |
| CAGR (3Y)Annualised 3-year return | +1.1% | -9.3% | +26.8% | -24.6% | -3.5% |
Risk & Volatility
Evenly matched — EXLS and IBM each lead in 1 of 2 comparable metrics.
Risk & Volatility
EXLS is the less volatile stock with a 0.64 beta — it tends to amplify market swings less than EPAM's 1.11 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IBM currently trades 70.7% from its 52-week high vs EPAM's 44.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.64x | 0.80x | 1.00x | 1.11x | 0.71x |
| 52-Week HighHighest price in past year | $48.54 | $325.71 | $324.90 | $222.53 | $87.03 |
| 52-Week LowLowest price in past year | $26.94 | $172.52 | $220.72 | $98.76 | $50.19 |
| % of 52W HighCurrent price vs 52-week peak | +64.0% | +55.4% | +70.7% | +44.6% | +59.4% |
| RSI (14)Momentum oscillator 0–100 | 52.3 | 41.9 | 43.9 | 20.7 | 27.6 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 5.6M | 5.3M | 1.3M | 5.8M |
Analyst Outlook
Evenly matched — ACN and IBM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EXLS as "Buy", ACN as "Buy", IBM as "Hold", EPAM as "Buy", CTSH as "Hold". Consensus price targets imply 66.2% upside for ACN (target: $300) vs 29.5% for EXLS (target: $40). For income investors, ACN offers the higher dividend yield at 3.24% vs CTSH's 2.45%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $40.25 | $299.92 | $309.64 | $158.00 | $81.75 |
| # AnalystsCovering analysts | 19 | 53 | 50 | 37 | 51 |
| Dividend YieldAnnual dividend ÷ price | — | +3.2% | +2.9% | — | +2.4% |
| Dividend StreakConsecutive years of raises | 1 | 14 | 30 | — | 9 |
| Dividend / ShareAnnual DPS | — | $5.85 | $6.59 | — | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | +6.8% | +4.1% | 0.0% | 0.0% | +5.6% |
IBM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). EPAM leads in 1 (Valuation Metrics). 2 tied.
EXLS vs ACN vs IBM vs EPAM vs CTSH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EXLS or ACN or IBM or EPAM or CTSH a better buy right now?
For growth investors, EPAM Systems, Inc.
(EPAM) is the stronger pick with 15. 4% revenue growth year-over-year, versus 7. 0% for Cognizant Technology Solutions Corporation (CTSH). Cognizant Technology Solutions Corporation (CTSH) offers the better valuation at 11. 4x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate ExlService Holdings, Inc. (EXLS) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EXLS or ACN or IBM or EPAM or CTSH?
On trailing P/E, Cognizant Technology Solutions Corporation (CTSH) is the cheapest at 11.
4x versus International Business Machines Corporation at 20. 6x. On forward P/E, EPAM Systems, Inc. is actually cheaper at 7. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ExlService Holdings, Inc. wins at 0. 57x versus EPAM Systems, Inc. 's 2. 07x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EXLS or ACN or IBM or EPAM or CTSH?
Over the past 5 years, International Business Machines Corporation (IBM) delivered a total return of +88.
3%, compared to -78. 4% for EPAM Systems, Inc. (EPAM). Over 10 years, the gap is even starker: EXLS returned +218. 8% versus CTSH's -0. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EXLS or ACN or IBM or EPAM or CTSH?
By beta (market sensitivity over 5 years), ExlService Holdings, Inc.
(EXLS) is the lower-risk stock at 0. 64β versus EPAM Systems, Inc. 's 1. 11β — meaning EPAM is approximately 73% more volatile than EXLS relative to the S&P 500. On balance sheet safety, EPAM Systems, Inc. (EPAM) carries a lower debt/equity ratio of 4% versus 2% for International Business Machines Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — EXLS or ACN or IBM or EPAM or CTSH?
By revenue growth (latest reported year), EPAM Systems, Inc.
(EPAM) is pulling ahead at 15. 4% versus 7. 0% for Cognizant Technology Solutions Corporation (CTSH). On earnings-per-share growth, the picture is similar: International Business Machines Corporation grew EPS 73. 7% year-over-year, compared to -14. 3% for EPAM Systems, Inc.. Over a 3-year CAGR, EXLS leads at 13. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EXLS or ACN or IBM or EPAM or CTSH?
International Business Machines Corporation (IBM) is the more profitable company, earning 15.
7% net margin versus 6. 9% for EPAM Systems, Inc. — meaning it keeps 15. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTSH leads at 16. 7% versus 9. 6% for EPAM. At the gross margin level — before operating expenses — IBM leads at 59. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EXLS or ACN or IBM or EPAM or CTSH more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ExlService Holdings, Inc. (EXLS) is the more undervalued stock at a PEG of 0. 57x versus EPAM Systems, Inc. 's 2. 07x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, EPAM Systems, Inc. (EPAM) trades at 7. 7x forward P/E versus 18. 5x for International Business Machines Corporation — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACN: 66. 2% to $299. 92.
08Which pays a better dividend — EXLS or ACN or IBM or EPAM or CTSH?
In this comparison, ACN (3.
2% yield), IBM (2. 9% yield), CTSH (2. 4% yield) pay a dividend. EXLS, EPAM do not pay a meaningful dividend and should not be held primarily for income.
09Is EXLS or ACN or IBM or EPAM or CTSH better for a retirement portfolio?
For long-horizon retirement investors, Cognizant Technology Solutions Corporation (CTSH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
71), 2. 4% yield). Both have compounded well over 10 years (CTSH: -0. 4%, EPAM: +41. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EXLS and ACN and IBM and EPAM and CTSH?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: EXLS is a small-cap quality compounder stock; ACN is a mid-cap deep-value stock; IBM is a large-cap quality compounder stock; EPAM is a small-cap high-growth stock; CTSH is a mid-cap deep-value stock. ACN, IBM, CTSH pay a dividend while EXLS, EPAM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.